BlackRock, Inc. 13D and 13G filings for TCR2 Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | TCR2 THERAPEUTICS INC TCRR | BlackRock Inc. BLK | 1,037,694 2.700% | -1,364,051 (-56.79%) | Filing |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | TCR2 THERAPEUTICS INC TCRR | BlackRock Inc. BLK | 2,401,745 6.300% | -201,794 (-7.75%) | Filing |